Astria Therapeutics: Oppenheimer raises Astria Therapeutics’ PT from $ 5 to $ 30 after reverse 1-for-6 stock split, continues to outperform rating

Newswires MT 2021

All the news on ASTRIA THERAPEUTICS, INC.

Analyst Recommendations on ASTRIA THERAPEUTICS, INC.
Sales 2021

Net income 2021 -207 million

Net debt 2021

PER 2021 ratio -0.29x
Yield 2021
Capitalization 124 million
124 million
Capi. / Sales 2021
Capi. / Sales 2022
Number of employees 20
Free float 100.0%

Chart ASTRIA THERAPEUTICS, INC.
Duration :

Period:

Astria Therapeutics, Inc. Technical Analysis Chart |  MarketScreener

Trends in Technical Analysis ASTRIA THERAPEUTICS, INC.

Short term Mid Road Long term
Tendencies Neutral Bearish Bearish

Evolution of the income statement

To sell

To buy

Average consensus TO BUY
Number of analysts 4
Last closing price

$ 9.66

Average price target

$ 23.75

Spread / Average target 146%

About Jason Norton

Check Also

Wabtec shares increased by almost 38% in 2021

Both investment income and net income increased in the first nine months of 2021 to …

Leave a Reply

Your email address will not be published. Required fields are marked *